Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.42 USD | +6.05% |
|
-6.04% | +101.18% |
Jun. 12 | Connect Biopharma Names New Chief Executive, Chair | MT |
May. 29 | Heron Therapeutics Submits Prior Approval Supplement to the FDA for Zynrelef Vial Access Needle | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+101.18% | 515M | |
+34.01% | 51.07B | |
+33.84% | 38.86B | |
-8.02% | 38.78B | |
-8.98% | 26.69B | |
+12.56% | 26.35B | |
-19.62% | 19.46B | |
+39.18% | 13.58B | |
+31.47% | 12.46B | |
-3.40% | 11.75B |
- Stock Market
- Equities
- HRTX Stock
- News Heron Therapeutics, Inc.
- Heron Therapeutics, Inc. Provides Sales Guidance for the Full Year 2021